Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-19-000065
Filing Date
2019-04-24
Accepted
2019-04-23 18:14:46
Documents
4
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A proxynotice2019.htm DEFA14A 18334
2 ligandlogo41719a02.jpg GRAPHIC 12141
3 noticecard1of2.jpg GRAPHIC 355020
4 noticecard2of2.jpg GRAPHIC 279082
  Complete submission text file 0000886163-19-000065.txt   893318
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 19762335
SIC: 2834 Pharmaceutical Preparations